BusinessWellDoc Announces Providence Health & Services’ Implementation of BlueStar® Digital Therapeutic in a Pilot Program for Individuals with Type 2 DiabetesBy Nasdaq OMXApr 3, 2018, 1:01 PM UTC
BusinessU.S. Preventive Medicine and Solera Health Partner to Deliver Comprehensive Health Coaching and Nurse Based Chronic Condition Care Management ServicesBy Nasdaq OMXFeb 20, 2018, 3:00 PM UTC
BusinessVirta Health's Treatment for Sustained Type 2 Diabetes Reversal Provides New Hope for Chronic Disease PatientsBy Nasdaq OMXFeb 7, 2018, 8:00 PM UTC
BusinessSolera Health and WellDoc Partner to Offer Health Plans and Employers a Holistic Approach to Diabetes Prevention and ManagementBy Nasdaq OMXJan 17, 2018, 3:00 PM UTC
BusinessVoluntis and WellDoc Announce Partnership to Combine Diabetes Digital Therapeutic OfferingsBy Nasdaq OMXJan 9, 2018, 2:02 PM UTC
BusinessWellDoc Validates Potential of Its Digital Therapeutic, BlueStar®, to Significantly Reduce Healthcare CostsBy Nasdaq OMXJan 4, 2018, 2:00 PM UTC
BusinessIQVIA Institute Rates WellDoc’s BlueStar® as “Top App” in Clinical Diabetes TreatmentBy Nasdaq OMXNov 13, 2017, 3:52 PM UTC
BusinessPatient Entrepreneur Amin Zayani of Med Angel BV Selected as the Winner of the 2017 Lyfebulb-Novo Nordisk Innovation AwardBy Nasdaq OMXNov 8, 2017, 2:14 PM UTC
